Profilo
Reid P.
Bissonnette currently works at Xenetic Biosciences, Inc., as Head-Translational Research & Development.
Dr. Bissonnette also formerly worked at Ligand Pharmaceuticals, Inc., as Associate Director, Huyabio International LLC, as Vice President-Pharmacology, Targazyme, Inc., as Vice President-Immuno-Oncology, and Arrivent BioPharma, Inc., as Head-Non-Clinical Research.
Dr. Bissonnette received his undergraduate degree and doctorate degree from McGill University.
Posizioni attive di Reid Bissonnette
| Società | Posizione | Inizio |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Reid Bissonnette
| Società | Posizione | Fine |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Corporate Officer/Principal | - |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
| ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | - |
Formazione di Reid Bissonnette
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
















